IONIS PHARMACEUTICALS INC — All Filings
1,001 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B2
424B3
424B4
424B5
424B7
5
8-K
8-K/A
ARS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NO ACT
POS AM
PRE 14A
REGDEX
S-3
S-3/A
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SC TO-T
SC TO-T/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001551 | Mar 27, 2026 | — |
| 144/A | — | 0001972481-26-000116 | Mar 24, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000152 | Mar 23, 2026 | Mar 19, 2026 |
| 144 | — | 0001972481-26-000114 | Mar 19, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000146 | Mar 18, 2026 | Mar 16, 2026 |
| 144 | — | 0001972481-26-000103 | Mar 16, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000144 | Mar 11, 2026 | Mar 9, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000142 | Mar 11, 2026 | Mar 10, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000143 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001972481-26-000093 | Mar 10, 2026 | — |
| 144 | — | 0001972481-26-000092 | Mar 9, 2026 | — |
| 8-K | 8-K | 0001140361-26-008340 | Mar 9, 2026 | Mar 3, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000137 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000136 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000138 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000134 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000133 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000135 | Mar 5, 2026 | Mar 3, 2026 |
| 144 | — | 0001972481-26-000077 | Mar 3, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000121 | Mar 3, 2026 | Feb 27, 2026 |
| 144/A | — | 0001972481-26-000083 | Mar 3, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000124 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000125 | Mar 3, 2026 | Feb 27, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000122 | Mar 3, 2026 | Feb 27, 2026 |
| 144 | — | 0001972481-26-000078 | Mar 3, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000123 | Mar 3, 2026 | Feb 27, 2026 |
| 144 | — | 0001972481-26-000080 | Mar 3, 2026 | — |
| 144 | — | 0001972481-26-000081 | Mar 3, 2026 | — |
| 144 | — | 0001972481-26-000082 | Mar 3, 2026 | — |
| 10-K | IONIS PHARMACEUTICALS, INC. 10-K 12-31-2025 | 0000874015-26-000115 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001140361-26-006718 | Feb 25, 2026 | — |
| SCHEDULE 13G/A | — | 0001897612-26-000248 | Feb 17, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000111 | Feb 13, 2026 | — |
| 144 | — | 0001972481-26-000055 | Feb 13, 2026 | — |
| 4/A | PRIMARY DOCUMENT | 0000874015-26-000112 | Feb 13, 2026 | Feb 2, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000110 | Feb 13, 2026 | Feb 11, 2026 |
| 144 | — | 0001972481-26-000053 | Feb 11, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000106 | Feb 10, 2026 | Feb 6, 2026 |
| 144 | — | 0001972481-26-000045 | Feb 6, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000104 | Feb 4, 2026 | Feb 2, 2026 |
| 144 | — | 0001972481-26-000034 | Feb 2, 2026 | — |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000095 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000102 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000096 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000097 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000098 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000099 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000100 | Feb 2, 2026 | Jan 29, 2026 |
| 4 | PRIMARY DOCUMENT | 0000874015-26-000101 | Feb 2, 2026 | Jan 29, 2026 |
| 144 | — | 0000874015-26-000086 | Jan 30, 2026 | — |